BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 27915186)

  • 1. Role of the purinergic signaling in epilepsy.
    Cieślak M; Wojtczak A; Komoszyński M
    Pharmacol Rep; 2017 Feb; 69(1):130-138. PubMed ID: 27915186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracellular ATP differentially affects epileptiform activity via purinergic P2X7 and adenosine A1 receptors in naive and chronic epileptic rats.
    Klaft ZJ; Schulz SB; Maslarova A; Gabriel S; Heinemann U; Gerevich Z
    Epilepsia; 2012 Nov; 53(11):1978-86. PubMed ID: 23106524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How is the P2X7 receptor signaling pathway involved in epileptogenesis?
    Wei C; Fu M; Zhang H; Yao B
    Neurochem Int; 2024 Feb; 173():105675. PubMed ID: 38211839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transient P2X7 Receptor Antagonism Produces Lasting Reductions in Spontaneous Seizures and Gliosis in Experimental Temporal Lobe Epilepsy.
    Jimenez-Pacheco A; Diaz-Hernandez M; Arribas-Blázquez M; Sanz-Rodriguez A; Olivos-Oré LA; Artalejo AR; Alves M; Letavic M; Miras-Portugal MT; Conroy RM; Delanty N; Farrell MA; O'Brien DF; Bhattacharya A; Engel T; Henshall DC
    J Neurosci; 2016 Jun; 36(22):5920-32. PubMed ID: 27251615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of purinergic signaling in depressive disorders.
    Sperlagh B; Csolle C; Ando RD; Goloncser F; Kittel A; Baranyi M
    Neuropsychopharmacol Hung; 2012 Dec; 14(4):231-8. PubMed ID: 23269209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purinergic signaling in kidney disease.
    Menzies RI; Tam FW; Unwin RJ; Bailey MA
    Kidney Int; 2017 Feb; 91(2):315-323. PubMed ID: 27780585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of purinergic system in the release of cytokines by macrophages exposed to glioma-conditioned medium.
    Bergamin LS; Braganhol E; Figueiró F; Casali EA; Zanin RF; Sévigny J; Battastini AM
    J Cell Biochem; 2015 May; 116(5):721-9. PubMed ID: 25546398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulators of nucleoside metabolism in the therapy of brain diseases.
    Boison D
    Curr Top Med Chem; 2011; 11(8):1068-86. PubMed ID: 21401494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenosine dysfunction in epilepsy.
    Boison D
    Glia; 2012 Aug; 60(8):1234-43. PubMed ID: 22700220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ATPergic signalling during seizures and epilepsy.
    Engel T; Alves M; Sheedy C; Henshall DC
    Neuropharmacology; 2016 May; 104():140-53. PubMed ID: 26549853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of purinergic receptors and NOD-like receptor-family protein 3-inflammasome pathway in the adenosine triphosphate-induced cytokine release from macrophages.
    Gicquel T; Victoni T; Fautrel A; Robert S; Gleonnec F; Guezingar M; Couillin I; Catros V; Boichot E; Lagente V
    Clin Exp Pharmacol Physiol; 2014 Apr; 41(4):279-86. PubMed ID: 24472059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The adenosine kinase hypothesis of epileptogenesis.
    Boison D
    Prog Neurobiol; 2008 Mar; 84(3):249-62. PubMed ID: 18249058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purinergic receptors: new targets for the treatment of gout and fibrosis.
    Gicquel T; Le Daré B; Boichot E; Lagente V
    Fundam Clin Pharmacol; 2017 Apr; 31(2):136-146. PubMed ID: 27885718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. P2 purinergic receptors signal to STAT3 in astrocytes: Difference in STAT3 responses to P2Y and P2X receptor activation.
    Washburn KB; Neary JT
    Neuroscience; 2006 Oct; 142(2):411-23. PubMed ID: 16905269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of P2X7 Receptor Ameliorates Nuclear Factor-Kappa B Mediated Neuroinflammation Induced by Status Epilepticus in Rat Hippocampus.
    Huang C; Chi XS; Li R; Hu X; Xu HX; Li JM; Zhou D
    J Mol Neurosci; 2017 Oct; 63(2):173-184. PubMed ID: 28856625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenosinergic signaling in epilepsy.
    Boison D
    Neuropharmacology; 2016 May; 104():131-9. PubMed ID: 26341819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenosine kinase and adenosine receptors A
    Patodia S; Paradiso B; Garcia M; Ellis M; Diehl B; Thom M; Devinsky O
    Epilepsia; 2020 Apr; 61(4):787-797. PubMed ID: 32243580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seizure suppression and neuroprotection by targeting the purinergic P2X7 receptor during status epilepticus in mice.
    Engel T; Gomez-Villafuertes R; Tanaka K; Mesuret G; Sanz-Rodriguez A; Garcia-Huerta P; Miras-Portugal MT; Henshall DC; Diaz-Hernandez M
    FASEB J; 2012 Apr; 26(4):1616-28. PubMed ID: 22198387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenosine Kinase Deficiency in the Brain Results in Maladaptive Synaptic Plasticity.
    Sandau US; Colino-Oliveira M; Jones A; Saleumvong B; Coffman SQ; Liu L; Miranda-Lourenço C; Palminha C; Batalha VL; Xu Y; Huo Y; Diógenes MJ; Sebastião AM; Boison D
    J Neurosci; 2016 Nov; 36(48):12117-12128. PubMed ID: 27903722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of purinergic receptors in the Alzheimer's disease.
    Cieślak M; Wojtczak A
    Purinergic Signal; 2018 Dec; 14(4):331-344. PubMed ID: 30362042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.